Investor Sentiment (Inverted) -- 4/10

This dimension is inverted -- negative sentiment is a positive signal (contrarian opportunity), while bullish sentiment is negative (crowded trade). BUD scores a 4, reflecting a moderately favorable contrarian setup. The bullish case is consensus -- 90% Buy ratings, $86-94 targets, and the Street enthusiastically embracing the premiumization and Beyond Beer pivot. However, the stock is meaningfully off its highs (down ~13% from 52-week high, down 24.5% over three months), and there is a genuine management-street tension on the Bud Light recovery narrative where management optimism outpaces brand-level data. The ADR is relatively under-owned by US institutions at ~5.5%, and the BEES Marketplace represents authentic optionality the Street has not fully modeled. This is not a fully crowded long, but directional consensus is firmly bullish. Weight: 15%

Factor	Assessment	Inverted Impact
Analyst Ratings	~90% Buy, consensus Strong Buy	Unfavorable -- crowded bullish, little room for positive surprise from upgrades
Price Target Upside	21-32% implied upside ($86-94 targets)	Mixed -- large gap suggests conviction, but also well-known targets with no hidden catalyst
ADR Institutional Ownership	~5.5% -- unusually low for $138B cap	Favorable -- under-owned by US institutions, less crowding risk than typical mega-caps
Stock vs. 52-wk High	Down ~13% from $81.56, -24.5% over 3 months	Favorable -- underperforming own sector, some positioning unwind already reflected
Bud Light Narrative	Sales still down ~30% YoY, brand at third place	Favorable -- narrative fatigue, incremental negative surprise limited, largely priced in
Management-Street Divergence	Management optimistic on US recovery; data shows Bud Light still declining	Favorable -- real divergence creates exploitable tension if narrative shifts
BEES Marketplace	GMV +61% to $3.5B, not yet modeled by Street	Favorable -- positive divergence where management vision exceeds street expectations
EM Exposure (~70% EBITDA)	Long-term growth but FX and macro risk	Neutral -- street prices as positive; EM slowdowns (Brazil, China) could persist

Divergence assessment: This is a real divergence. Management is conspicuously framing US momentum around Michelob Ultra, Busch Light, and Beyond Beer while sidestepping Bud Light brand-level declines that remain severe (~30% YoY). The Street largely accepts this pivot narrative -- hence ~90% Buy ratings -- but the stock price suggests the broader market is less convinced, with 24.5% three-month underperformance vs. the beer industry. The China weakness is particularly notable: management frames it as cyclical alongside weather and consumer headwinds, but then acknowledges the need to "rebuild momentum" -- language that implies structural challenges. The tension is exploitable: if Bud Light stabilizes or BEES acceleration continues, the current price embeds meaningful upside; if the US volume decline broadens beyond Bud Light, the consensus bull case unravels.

Firm	Action	Date	Detail
JPMorgan	Reaffirmed Buy	April 2026	Continued conviction in premiumization and Beyond Beer pivot
UBS	Reiterated Buy	March 2026	Maintained bullish stance on global portfolio diversification
Consensus	~12 Buy / 4 Hold / 0-1 Sell	Current	Average target $86-94 implies 21-32% upside from $71.30 | No downgrades in recent months

Factor	Detail	Sentiment Impact
Price Positioning	$71.30, down ~13% from 52-wk high of $81.56 | -24.5% over 3 months vs. beer industry -16.4%	Contrarian opportunity -- negative sentiment already reflected in price despite bullish ratings
ADR Ownership	~5.5% institutional on ADR | Primary listing ABI (Euronext) captures most ownership	Under-owned by US institutions -- less crowding risk than typical mega-caps
Bud Light Narrative Fatigue	Boycott story nearly 3 years old | Most investors already made their judgment	Limited incremental negative surprise potential -- market has priced in permanent share loss
BEES Marketplace	GMV grew 61% to $3.5B in 2025 | 3P scaling rapidly | 1.5-2x addressable revenue beyond beer	Under-appreciated -- Street not modeling meaningful BEES contribution yet
EM Exposure (~70% EBITDA)	Long-term growth from developing markets | FX and macro risk | Brazil and China softness in 2025	Double-edged -- Street prices as positive but EM consumer slowdowns could persist

Contradiction 1: US momentum vs. Bud Light reality. Management claims the US business is "building momentum" and gained share in beer and spirits. But Bud Light -- historically the flagship brand -- is still down ~30% YoY with shelf space cuts of up to 7.5%. The share gains come from Michelob Ultra, Busch Light, and Beyond Beer, not from the core brand recovering. Management is pivoting around the hole, not filling it, while the earnings call narrative implies broader recovery.

Contradiction 2: Volume weakness framed as transient but China acknowledged as structural. Management attributed soft volumes to "unseasonable weather" and a "constrained consumer environment" -- cyclical and temporary factors. But for China specifically (revenue down low teens), management acknowledged the need to "rebuild momentum and reignite growth," language that concedes structural challenges. The same framing cannot be consistently cyclical for LatAm and structural for China when both are volume headwinds.

Contradiction 3: Bullish consensus vs. price weakness. ~90% of analysts maintain Buy ratings with $86-94 targets (21-32% upside), yet the stock has underperformed the beer industry by 8 percentage points over three months. The market is pricing in risk that the sell-side is not. Either the Street is right and the stock is mispriced, or the consensus bull case has a blind spot the market sees.

4/10 (Inverted) -- Moderately favorable contrarian setup. Consensus is bullish but not euphoric, with enough unpriced optionality and price weakness to offer moderate opportunity.

Why not lower (1-3, extremely crowded): Several factors prevent this from being a fully crowded long. The stock is meaningfully off its highs with recent underperformance vs. the sector, suggesting some positioning unwind. There is a genuine management-street tension on the Bud Light recovery where management optimism outpaces brand-level data. The ADR is relatively under-owned by US institutions at ~5.5%. The BEES platform (GMV +61% to $3.5B) and Beyond Beer acceleration represent authentic optionality the Street has not fully modeled. The 24.5% three-month decline has created a less euphoric setup than six months ago.

Why not higher (5-7, meaningfully contrarian): The consensus is directionally correct that the diversified global footprint and capital return improvements are real. The ~20x P/E is not demanding for a consumer staples compounder, and 4-8% EBITDA guidance is achievable. ~90% Buy ratings with $86-94 targets leaves little room for positive surprise from upgrades. No downgrades in recent months means the sell-side is not reconsidering. Management guidance is moderate, not aggressive -- reducing the probability of a negative guidance surprise. The bullish thesis (premiumization, Beyond Beer, capital return) is well-understood by all market participants.

Bottom line: BUD is a stock where consensus sentiment is bullish but not euphoric, with enough unpriced optionality (BEES, Beyond Beer) and price weakness (24.5% three-month decline) to offer moderate contrarian opportunity. The real edge is in the management-street divergence on Bud Light and the under-appreciated BEES platform. Monitor Bud Light brand-level data for stabilization signals and BEES GMV trajectory for positive divergence confirmation.